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INTRODUCTION
Competitions for survival occur everywhere between living beings. Niche competition among bacteria in natural environments is fierce and often influences the pathogenesis and progress of certain human diseases during polymicrobial infections (1) (2) (3) (4) . In recent years, studies have identified that the type VI secretion system (T6SS) of Gram-negative bacteria not only serves as a virulence factor that directly attacks host cells, but it also participates in competitive interbacterial interactions by translocating effector proteins into rival cells (5) (6) (7) (8) (9) . The important role of T6SS in interbacterial interactions in association with its presence in many disease cases caused by bacterial pathogens implies that it may be crucial in certain human polymicrobial infections.
It is now known that T6SS is a specialized protein secretory apparatus evolved by Gram-negative bacteria to deliver effector proteins into target cells in a cell contact-dependent manner. Two conserved T6SS components, hemolysin coregulated protein (Hcp) and valine-glycine repeat protein G (VgrG), have been structurally characterized and have remarkable homology to bacteriophage tail proteins (10-12). These findings prompt the speculation that T6SS may assemble as an inverted phage tail across the envelope of bacteria, targeting bacterial cells by a puncturing manner analogous to bacteriophage entry (13, 14) . However, the mechanism underlying effector delivery through this secretory apparatus and the functions of the effectors in recipient cells remain unclear.
Most recently, it was demonstrated that the haemolysin co-regulated protein secretion island I (HSI-I)-encoded T6SS (H1-T6SS) of Pseudomonas aeruginosa plays an important role in P. aeruginosa competition with other Gram-negative bacteria (15, 16) . The system delivers two novel effector proteins, Tse1 and Tse3, into target bacterial cells, which breach the barrier of the Gram-negative outer membrane by virtue of the T6SS and act as lytic enzymes that hydrolyze the murein in the periplasm of recipient cells (16) . Interestingly, P. aeruginosa cannot distinguish between its siblings and other bacteria and thus the bacteria export these effectors into each other through the T6SS. To protect against mutual toxicity, P. aeruginosa produces two immunity proteins (Tsi1 and Tsi3) that specifically inactivate their cognate effectors (16) . These findings indicate an ingenious bacterial niche competition strategy. Exploring the molecular mechanism of this strategy using a 3D structural basis of the effectors and their specific immune proteins is of great significance for understanding interbacterial competitive interactions and also provides potential application value in the development of effective antibacterial agents and approaches.
Tse1 has been functionally characterized as a DL-endopeptidase that specifically hydrolyzes the γ-D-glutamyl-L-meso-diaminopimelic acid (γ-D-glutamyl-DAP) linkage in the murein peptide bridge (16) . However, the underlying mechanism for the recognition and cleaving of the murein peptide substrate by Tse1 has remained elusive because of the low primary sequence homology with known DL-endopeptidases and the lack of a solved structure for this T6SS effector. The immunity protein Tsi1, which is only detected in P. aeruginosa, also bears no significant sequence homology to characterized proteins. Therefore, the question of how Tsi1 specifically inactivates Tse1 to protect P. aeruginosa against mutual toxicity has remained open. In this paper, we report on the crystal structures of Tse1 and its complex with Tsi1. These findings build a structural framework for the understanding of the bacteriolysis mechanisms underlying the T6SS effectors and self-protection via corresponding immunity proteins. In addition, these findings provide a structural basis for antibacterial agent design and the development of new strategies to fight P. aeruginosa.
EXPERIMENTAL PROCEDURES
Protein expression and purification-The gene sequences encoding the full-length Tse1 and truncated Tsi1 without the N-terminal 19-residue signal peptide were synthesized with proper optimization to reduce the high GC contents (Sangon Biotech, Shanghai, China). Then, both genes were subcloned into a pET-28a vector (Novagen, Darmstadt, Germany) between NdeI and XhoI sites, which resulted in an N-terminal fusion sequence (MGSSHHHHHHSSGLVPRGSHM). The mutants were generated by site-directed mutagenesis using the wild-type (wt) vector as the template and confirmed by DNA sequencing. The proteins were overexpressed in E. coli strain BL21 (DE3) (Novagen, Darmstadt, Germany) grown in LB medium and induced with 0.2 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) overnight at 289 K. Bacterial pellets were harvested by centrifugation at 4,000 g and then resuspended in lysis buffer (300 mM NaCl, 50 mM NaH 2 PO 4 /Na 2 HPO 4 pH 7.5 and 10 mM imidazole) with 0.1 mM PMSF and lysed by sonication in an ice bath. After centrifugation, the soluble proteins were first purified using Ni 2+ -resin (Novagen, Darmstadt, Germany) and then diluted with buffer A (100 mM NaCl, 50 mM Tris pH 8.0 and 1% v/v glycerol), followed by a thrombin digestion of the His 6 tag. A second nickel chromatography step was performed, and the flow-through proteins were collected and concentrated. Tse1 was further purified by cation-exchange (HiTrap SP HP column, GE Healthcare, Uppsala, Sweden) and gel-filtration (Hiload 16/60 Superdex 75 column, GE Healthcare, Uppsala, Sweden) chromatography. Selenomethionine-substituted (SeMet) Tse1 was produced by expression in the E. coli methionine auxotrophic strain B834 (DE3). The purification procedure for the SeMet derivative was the same as that of the native protein. Tsi1 was further purified by anion-exchange (HiTrap Q HP column, GE Healthcare, Uppsala, Sweden) and gel-filtration (Hiload 16/60 Superdex 75 column, GE Healthcare, Uppsala, Sweden) chromatography. All the Tsi1 mutants were expressed and purified using the same protocol. The Tse1-Tsi1 complex was obtained by mixing two proteins with excess Tse1 followed by gel-filtration (Hiload 16/60 Superdex 75 column, GE Healthcare, Uppsala, Sweden) chromatography. All purified proteins were stored in buffer A (5 mM dithiothreitol and 0.2 mM EDTA added for the Se-Met protein) at 193 K. Crystallization and data collection-The crystallization experiments were performed using the hanging-drop vapor-diffusion method at 293 K with 2 µl drops containing a 1-µl protein solution and 1-µl reservoir solution equilibrated over a 0.5-ml reservoir solution. Initial crystallization hits were found using an Index Kit (Hampton Research, Aliso Viejo, CA, USA). The Tse1 crystals and SeMet-labeled Tse1 were grown in 1.8 M sodium formate and 50 mM MES pH 6.2. The Tse1-Tsi1 complex crystals were grown from a solution of 20% (v/v) PEG4000, 100 mM sodium citrate pH 5.4 and 20% (v/v) isopropanol.
The single-wavelength anomalous diffraction (SAD) data set for SeMet-labeled Tse1 was collected at beamline 3W1A of the Beijing Synchrotron Radiation Facility (Beijing, China). The high-resolution data set of Tse1 and the Tse1-Tsi1 complex data set were collected at beamline 17A of the Photon Factory (KEK, Tsukuba, Japan). Prior to data collection, all of the crystals were transferred to a well solution supplied with 10% (v/v) ethylene glycol as a cryoprotectant.
Structure determination and refinement-All the data sets were processed with MOSFLM and scaled with SCALA from the CCP4 program suite (17). Phase determination and automatic model building of Tse1 were performed with PHENIX (18) . The rest of the model was manually built with COOT (19) . The refinement was carried out with PHENIX. The structure of the Tse1-Tsi1 complex was solved by molecular replacement with PHASER of the CCP4 program suite using the apo-Tse1 structure as a search model. Model building and structural refinement were performed with COOT and PHENIX, respectively. The statistics of data collection and refinement are summarized in Table 1 . The quality of the final model was checked by MolProbity (20) . Sequence alignment was generated by ClustalW (21) . Our sequence alignment figure was produced by ESPript (22) . All other figures were rendered in PyMOL (http://www.pymol.org).
E. coli growth curves-The Tse1 gene was also subcloned into a pET-22b vector (Novagen, Darmstadt, Germany) between the NcoI and XhoI sites for expression in the periplasm by fusion with an N-terminal signal peptide. The vector also added a C-terminal hexahistidine tag to the expressed protein, allowing for western blot analysis of expression. The catalytic residue mutants were generated by site-directed mutagenesis using the wt-Tse1 as the template. BL21 (DE3) pLysS cells harboring wt-Tse1 expression plasmids and mutant Tse1 were grown overnight in LB medium at 310 K and subinoculated to a starting optical density of approximately 0.06 at 600 nm (OD 600 ) in LB medium. The cultures were grown to OD 600 0.26-0.27 and induced with 0.1 mM IPTG. The OD 600 values of the cultures were recorded for growth curves. Protein expression levels were detected at 40 min after induction by western blot analysis against the anti-His antibody (Abmart, Shanghai, China) and the anti-β-lactamase antibody (Millipore, Billerica, USA). Tse1 and Tsi1 kinetic assay-Protein kinetics were investigated using a Surface Plasmon Resonance (SPR) Biacore T100 machine (GE Healthcare) at 298 K. The running buffer (50 mM HEPES pH 7.5, 100 mM NaCl, and 0.005% (v/v) Tween-20) was prepared, vacuum filtered and degassed immediately prior to use. One CM5 sensor chip flow cell was activated for 7 min with a 1:1 mixture of 0.1 M N-hydroxysuccinimide and 0.1 M N-ethyl-N'-(3-diethylaminopropyl)-carbodiimid e at a flow rate of 10 μl/min. Tse1, at a concentration of 2 μg/ml in 10 mM sodium acetate pH 5.0, was immobilized to 300 response units on the flow cell. The remaining binding sites were blocked by 1 M ethanolamine, pH 8.5.
The wt-Tsi1 and mutant Tsi1 proteins were injected at different concentrations over the Tse1 surface and blank flow cell for 2 min at a flow rate of 30 µl/min. After 2-4 min dissociation phase, bound protein was removed with a 30-s wash with 10 mM Gly-HCl pH 2.0. The resulting data were analyzed with Biacore T100 evaluation software by fitting to a 1:1 Langmuir binding model.
RESULTS
Overall structure of Tse1-Although Tse1 has been defined as a novel DL-endopeptidase that belongs to the superfamily of papain-like cysteine peptidases, determining the structure of Tse1 with available structures of other DL-endopeptidases as search models was unsuccessful. We solved the crystal structure of apo-Tse1 by Se-SAD at a-1.5 Å resolution. The structure of apo-Tse1 contains one Tse1 molecule in an asymmetric unit, which is consistent with the observation that Tse1 exists as a monomer in solution (Fig. 1A ). The final model comprises residues 3-154 of Tse1. The first two residues are not included in the final model due to the lack of interpretable electron density. The details of the crystallographic analysis are summarized in Table 1 .
Tse1 adopts a compact papain-like α+β fold that consists of six β strands (β1-β6) and five helices (α1-α5). The six β strands constitute a curved antiparallel β-sheet in the center of the structure, and the five helices flank each side of the central β-sheet (Fig. 1B) . Following the last β6 is a long flexible loop that is fixed by a disulfide bond between Cys148 within the loop and Cys7 located at the N-terminus of α1 (Fig.  1B) .
Extensive side-chain hydrophobic interactions play important roles in maintaining the integrated structure. Structural homology searches by DALI (23) (26) , and the peptidoglycan endopeptidases RipA and RipB from Mycobacterium tuberculosis (Z=7.1 and 7.2, PDB code 3NE0 and 3PBI) (27, 28) (Fig. 1C) . Structural comparisons between Tse1 and the NlpC/P60 domains of these DL-endopeptidases yield a moderate root mean-square deviation (rmsd) of 2.7-3.8 Å for 112 aligned Cα atoms, indicative of notable differences between them, particularly in the flexible loop connecting the conserved second structure elements. Tse1 catalytic site-As a branch of papain-like cysteine peptidases widespread in bacteria, NlpC/P60 DL-endopeptidases possess the highly conserved catalytic triad Cys-His-X (where X is a polar residue) in which the catalytic Cys-His pair hydrolyzes the substrate and the third polar residue orients the second His to the first Cys (29). Sequence alignment indicates that despite bearing a low sequence homology with other NlpC/P60 DL-endopeptidases, Tse1 retains the crucial catalytic Cys-His pair ( Supplementary Fig. 1 ). In the apo-Tse1 structure, the reactive Cys30 is located in the N-terminus of α2, spatially adjacent to the catalytic His91 located on the N-terminus of β3. Both catalytic residues could be well superimposed to their corresponding counterparts in other NlpC/P60 DL-endopeptidases ( Fig.  2A) . Upon superimposition of the catalytic Cys-His pairs, there is a variation of the third residue. In other NlpC/P60 DL-endopeptidases, this position is often occupied by another histidine (24) (25) (26) . Other polar residues, including Asn, Glu, Gln and Asp, also occur at this position, although with low frequency (27, 28) . Close inspection confirms that the third residue in the catalytic site of Tse1 is a cysteine (Cys110) located in the C-terminus of β4. Such an arrangement has not been previously observed in papain-like cysteine peptidases ( Fig. 2A) . Compared with the more commonly observed histidine, Cys110 directs its sulfhydryl group farther away from the imidazole group of the second histidine, with the distance between the Sγ of Cys110 and the Nδ1 of His91 being 3.51 Å. Cys110 is further stabilized by van der Waals interactions with the main-chain carbonyl group of Gly118 and the sulfhydryl group of the proximal Cys108 ( Fig.  2A) . In addition, another conserved tyrosine, which helps to form an "oxyanion hole" near its hydroxyl group in other NlpC/P60 DL-endopeptidases, has no counterpart but a serine (Ser112) at the corresponding Tse1 position ( Fig. 2A) . Ser112 is located on the flexible loop following Cys110, spatially adjacent to the reactive Cys30 and is probably responsible for the formation of the oxyanion hole. To further confirm the contributions of the catalytic residues of Tse1, we expressed the mutants of the catalytic residues in the periplasm and tested their capacities to lyse bacterial cells. The results demonstrate that mutation of either catalytic Cys30 or His91 to alanine greatly reduced the bacteriolytic activities of Tse1, whereas mutation of Cys110 to alanine had no obvious effect on bacteriolytic activity ( fig 2B) . These observations confirmed that Tse1 acts as a papain-like cysteine peptidase. The conserved catalytic Cys30-His91 pair plays an important role in the catalytic activities of Tse1, while Cys110 contributes little to the catalytic activities of Tse1. The potential substrate-binding sites-Surface inspection indicates that on top of the catalytic site of Tse1 is a large cavity with three independent entrances (E1, E2 and E3) related by a pseudo three-fold axis (Fig. 3A) . Three protruding loops (β2-β3 loop, β4-β5 loop and α5-β6 loop) surround the cavity with two of them each bounding an entrance (Fig. 3B) . The distinct geometry of these areas indicates that they likely serve as the substrate-binding sites of Tse1 and recognize the cross-linked peptides of cell-wall murein (Fig. 3C) . Interestingly, in the structure of apo-Tse1, the C-terminus of a symmetry-related molecule runs across E2, makes a 90° turn in the cavity, and flaps to E3 (Fig. 3A) . In this way, the C-terminal flexible loop partially occupies the extensive substrate-binding sites, which, to a certain extent, mimics a portion of the Tse1 cross-linked murein peptide binding. In fact, the architecture of the substrate-binding sites could accommodate the cross-linked murein peptides well. Upon recognizing the cell wall peptidoglycan by Tse1, the acceptor murein tetrapeptide enters E2 with the extended glycan backbone out of the cavity, lying on the open surface of the protein. This tetrapeptide makes a fine turn in the cavity and directs the last residue to E3. The donor murein tetrapeptide enters E1 from the opposite direction. The scissile γ-D-glutamyl-DAP bond is clamped by Tyr89 in the β2-β3 loop and Ile113 in the β4-β5 loop, exposing it to the catalytic Cys30 for specific cleavage. The last residue stretches into the cavity and cross-links with the third residue of the other tetrapeptide (Fig. 3D) . Overall structure of Tse1-Tsi1 complex-To elucidate the protection mechanism of P. aeruginosa against mutual toxicity by Tsi1, the crystal structure of Tse1 in complex with Tsi1 was determined at a 2.5-Å resolution by molecular replacement with the structure of apo-Tse1 as the search model. Each asymmetric unit contains four Tse1-Tsi1 complexes arranged in a D2 point group. Only a few interactions are observed between these four complexes. In addition, the Tse1-Tsi1 complex indicates an apparent molecular mass of 34.9 kDa by analytical size exclusion chromatography (Fig.  1A) . These observations suggest that Tse1 and Tsi1 form a complex with 1:1 stoichiometry. The four Tse1-Tsi1 complexes in the asymmetric unit are likely the result of crystal packing and represent no significant biological relevance. The structures of Tse1 and Tsi1 in the four complexes are essentially identical, with C α rmsd of approximately 0.22 to 0.36 Å and approximately 0.29 to 0.48 Å for Tse1 and Tsi1, respectively. Thus, we hereafter confine our analyses and discussions to one Tse1-Tsi1 complex (composed of chain A for Tse1 and chain E for Tsi1). The final model of the Tse1-Tsi1 complex contains residues 3-148 of Tse1 and residues 21-168 of Tsi1. Bioinformatic analyses predict that the Tsi1 residues 1-19 compose a periplasmically localized signal peptide sequence and were truncated when we constructed the recombinant Tsi1 protein. Other terminal residues, comprising residues 1-2, 149-154 of Tse1 and residues 20, 169-172 of Tsi1 are omitted in the complex structure due to the lack of interpretable electron density. The details of the crystallographic analysis are summarized in Table 1 .
The structure of the Tse1-Tsi1 complex indicates that both proteins tightly interact with each other (Fig. 4A, B) Supplementary Fig. 2 ). In the complex, Tsi1 adopts an all β fold consisting of fourteen β strands (βa-βn), which constitute three antiparallel β-sheets (termed as sheet I, II and III) (Fig. 4C) . Sheet I consists of βa, βh, βi, βj and βk, located in the middle. Sheet II (composed of βb, βc, βd, βf and βg) and sheet III (composed of βl, βm and βn) are packed against each side of sheet I. The remaining short βe flanks the N-terminus of βh at the base. All the three sheets are curved and shaped like three blades (Fig.  4C ). DALI searches (23) with the structure of Tsi1 as the bait obtained several structures containing a typical β-propeller fold, such as dipeptidyl aminopeptidase IV from Stenotrophomonas maltophilia (Z=7.2, PDB code 2ECF) (30) . Although the structure of Tsi1 can be roughly superimposed with part of the characterized β-propeller fold ( Supplementary  Fig. 3 ), there are remarkable differences between them. The classic β-propeller is characterized by four to eight blade-shaped β-sheets arranged toroidally around a central axis. Each sheet typically has four antiparallel β-strands. However, Tsi1 only has three blade-shaped β-sheets that do not form an integrated circle. Additionally, the three β-sheets have unequal antiparallel β-strands unlike those in a β-propeller. The Tsi1-Tse1 interaction-At the interface of the Tse1-Tsi1 complex, Tsi1 has a unique topography characterized by protruding rigid βi-βj turns in the center surrounded by a circle of low-lying areas. This structural feature provides a perfect fit for binding of the substrate-binding sites of Tse1. In other words, Tsi1 adopts a unique interactive mode to specifically recognize Tsi1, which gives rise to extensive interactions between these two proteins (Fig. 5A) .
The extensive interactions can be divided into three principal regions: (1) The rigid Tsi1 βi-βj turn and insert into the cavity of Tse1, contacting the floor and interacting with the surrounding Tse1 β2-β3 loop, β4-β5 loop and α5-β6 loop (Fig. 5A, B) . This central region involves five hydrogen bonds. Among the interacting residues, Tsi1 Ser107 forms two strong hydrogen bonds with the main-chain of Tse1 Asn131 and the side-chain of Tse1 Asp134, supplemented by van der Waals interactions with the side-chain of Tse1 Asn131. Tsi1 Ser109 forms a hydrogen bond with the catalytic residue His91 of Tse1 and fixes its side-chain conformation. Furthermore, Tsi1 Phe106 interacts with Tse1 Val117 through side-chain hydrophobic interactions, further stabilizing the Tsi1-Tse1 interaction (Fig. 5B) . (2) The Tse1 β3-β4 loop and α5-β6 loop protrude into the low-lying area of Tsi1, contacting the Tsi1 βe-βf loop and βg-βh loop (Fig. 5A, C) . Tsi1 Glu65 forms three hydrogen bonds with the side-chains of Tse1, Tyr101 and Arg135, respectively, playing an important role in the Tsi1-Tse1 interaction in this region. In addition, Tsi1 Glu53 forms a salt bridge with Tse1 Arg102. As a supplement, Tsi1 Ile86 interacts with the main-chain of Tse1 Val129 through van der Waals interaction and constrains Tsi1 Phe106 in the central region through hydrophobic interactions (Fig. 5C) . (3) The extrusion of the Tse1 β4-β5 loop extends into the cleft of Tsi1 and is embraced by the Tsi1 βd-βe turn and βm-βn loop (Fig. 5A, D) . On one side, Tsi1 Arg133 forms a salt bridge with Tse1 Asp28. On the other side, Tsi1 Asp61 interacts with Tse1 Lys124 through a side-chain hydrogen bond. In the middle, Tsi1 Glu150 forms a hydrogen bond with the main-chain of Tse1 Ala116 (Fig. 5D) . Structural determinants of Tsi1-Tse1 recognition-The specific recognition mode and extensive interactions undoubtedly endow Tsi1 and Tse1 with tight binding. This speculation from the structural analyses was further confirmed by SPR experiments with a Biacore by guest on July 16, 2017 http://www.jbc.org/ Downloaded from T100. Wt-Tse1 was covalently coupled to the chip, and wt-or mutant Tsi1 proteins were injected in the microfluidic channel. The wt-Tsi1 and wt-Tse1 yielded a dissociation constant (K d ) of 2.77 nM ( Table 2, Fig. 6 ), indicative of a strong binding between Tsi1 and Tse1, even comparable to the binding affinity between antigen and antibody. However, upon mutating Tsi1 Ser107 to an alanine, the Tsi1-S107A mutant to wt-Tse1 K d value markedly decreased to 4.00 µM, an approximately 1500-fold reduction. In accordance with the change of binding affinity, the Tsi1-S107A mutant to wt-Tse1 association rate exhibited the same degree of reduction (Table 2, Fig. 6 ). These observations indicate that Tsi1 Ser107 in the βi-βj turn plays an indispensable role in Tsi1-Tse1 specific recognition. This finding is consistent with the broad interactions between this residue and neighboring Tse1 residues in the complex structure (Fig. 5B) . Moreover, substituting an alanine for Tsi1 Glu65 or Ile86 in the second Tse1-contacting region led to a 15-fold or 11-fold reduction, respectively, of the binding affinity, accompanied with a similar 9-fold decrease of the association rate ( Table 2 , Fig. 6 ). These results suggest that both residues also play important roles in Tsi1 recognizing Tse1. From the complex structure perspective, Tsi1 Glu65 and Ile86 protrude from the low-lying area with their side-chains responsible for specifically interacting with corresponding structural elements of Tse1 (Fig. 5C ). In addition, the Tsi1-F106A mutant also exhibited a 5-fold reduction in binding affinity to wt-Tse1. However, the Phe106 residue mainly contributes to the stabilization of the Tsi1-Tse1 interaction, as suggested by the notable 4-fold increase of the dissociation rate compared with wt and other mutant Tsi1 proteins (Table 2, Fig. 6 ). Other Tsi1 residues involved in the Tsi1-Tse1 interaction (Ser109, Asp61 and Glu150) were further confirmed to play subsidiary roles in the Tsi1-Tse1 interaction because mutations of these residues did not have any noticeable effects on any kinetic value compared with wt-Tsi1.
DISCUSSION
Tse1 adopts a papain-like structure to hydrolyze cross-linked murein peptide-Tse1 is a novel T6SS virulence effector employed by P. aeruginosa to compete with other bacteria. In this study, we uncovered that Tse1 adopts a typical papain-like structure and shares a high structural homology with known NlpC/P60 DL-endopeptidases (Fig. 1C) . However, unlike other NlpC/P60 DL-endopeptidases, Tse1 comprises a sole NlpC/P60 domain without any N-terminal signal peptide or fusion with other auxiliary domains, such as the bacterial SH3-like domain (Fig. 1C) .
Tse1 retains the conserved catalytic Cys-His pair of papain-like cysteine peptidases. Although harboring a novel variation of the third residue, the catalytic site of Tse1 features a spatial configuration closely resembling that of other papain-like cysteine peptidases ( Fig. 2A) . Therefore, the catalytic mechanism for γ-D-glutamyl-DAP bond cleavage by Tse1 is expected to be analogous to that of papain-like cysteine peptidases (26, 31) . His91 serves as a general base and deprotonates the sulfhydryl group of Cys30 to form a thiolate anion. The thiolate anion of Cys30 acts as a catalytic nucleophile and attacks the carbonyl carbon of the scissile γ-D-glutamyl-DAP bond in the murein peptide to turn the carbonyl oxygen into an oxyanion. The oxyanion is held by a side-chain of Ser112 that forms an oxyanion hole. The reaction is completed by activating a water molecule to hydrolyze the acyl-thioester bond to release the produced peptide and regenerate Tse1.
Prior to study of the P. aeruginosa T6SS effector Tse1, the bacterial NlpC/P60 DL-endopeptidases were characterized as endogenous hydrolases involved in the peptidoglycan recycling process during bacterial cell division and growth (32) and the peptidoglycan degradation process during bacterial cell autolysis (33) . Several of the endopeptidases act on the simple murein tetrapeptide comprising the specific γ-D-glutamyl-DAP bond. The fused auxiliary domains confer substrate specificity on these peptidoglycan hydrolase (24, 26) . However, as an exogenous peptidoglycan hydrolase delivered by T6SS, Tse1 directly faces the intact cell wall peptidoglycan and targets its specific γ-D-glutamyl-DAP linkage occurring in the cross-linked murein peptide. The Tse1 structure presents an extensive substrate-binding sites specific for cross-linked murein peptide recognition (Fig. 3D) . In fact, our structural analyses of the specific recognition for cross-linked murein peptide by Tse1 are consistent with previous biochemical studies. In cell wall peptidoglycan degradation assays, Tse1 exhibits a notable preference toward the breaking of the cross-linked murein peptide (16) , supporting the specific recognition of Tse1 of the amide bond in the cross-linked murein peptide as its best substrate. It is well known that the glycan chain linkage and the murein peptide cross-linkage are the main linkages maintaining the mesh-shaped architecture of the murein of Gram-negative bacteria. Together with another T6SS effector Tse3 that breaks the glycan chain linkage (16), Tse1 enables P. aeruginosa to destroy the structure of the murein of target cells and achieve bacteriolysis. Tsi1 inactivates Tse1 by blocking the substrate binding and cleavage of Tse1-Tsi1 adopts a novel three β-sheet structure to specifically interact with Tse1 via a unique interactive recognition mode (Fig. 5A) . Notably, the Tsi1-binding sites in Tse1 overlap with a large area of the substrate-binding sites of Tse1, including the cavity accommodating the cross-linkage in the cross-linked murein peptide substrate and E2 groove where the non-hydrolyzed murein tetrapeptide is located (Fig. 3A) . The high-affinity and specificity of the Tsi1-Tse1 interaction indicate that the occupancy of the substrate-binding sites of Tse1 by Tsi1 probably prevent Tse1 from binding to its cross-linked murein peptide substrate. Interestingly, in the structure of apo-Tse1, the flexible C-terminal loop of the symmetry-related molecule inserts into the substrate-binding sites of Tse1 and disappears in the structure of the Tse1-Tsi1 complex, indicating possible occupancy by Tsi1. Furthermore, the reactive Cys30 of Tse1 responsible for attacking the scissile γ-D-glutamyl-DAP bond in the substrate lies away from the Tsi1-binding sites on Tse1 and, in turn, might be incapable of breaking Tsi1 even with Tse1 as a cysteine peptidase. Therefore, we conclude that the possible structural mechanism for protection of P. aeruginosa against mutual bacteriolysis by Tsi1 is inactivation of Tse1. This inactivation is accomplished by Tsi1 functioning as an inhibitor occupying the substrate-binding sites of exogenous Tse1 and blocking the cross-linked murein peptide binding and cleavage of Tse1.
It is noteworthy that recent studies have found that Tse1 and its immune protein Tsi1 are not confined to P. aeruginosa. They also have homologues in other Gram-negative bacteria, suggestive of the generality of the competitive strategy adopted by P. aeruginosa (34) . Additionally, Tse1 comprises only a minimal functional unit of the papain-like cysteine peptidase, but it serves as an efficient factor for the killing of other bacteria by P. aeruginosa. Its specific toxicity to an essential bacterial cell component makes it a good antibacterial agent fighting against a number of Gram-negative pathogenic bacteria. The finding of an effective way to export this protein instead of T6SS is the next goal of application research. On the other hand, the important roles of Tse1 and Tsi1 for P. aeruginosa in killing rival cells and obtaining a growth advantage against other bacteria prompts the speculation that the proteins could also be potential anti-P. aeruginosa targets. The atomic coordinates and structure factor files of Tse1 and Tse1-Tsi1 complex have been deposited in the PDB with the accession codes 3VPI and 3VPJ, respectively.
The abbreviations used are: T6SS, type VI secretion system; Tse1, type VI secretion exported 1; Tsi1, Tse1-specific immunity protein; Hcp, hemolysin coregulated protein; VgrG, valine-glycine repeat protein G; HSI-I, haemolysin co-regulated protein secretion island I; γ-D-glutamyl-DAP, γ-D-glutamyl-L-meso-diaminopimelic acid; IPTG, isopropyl β-D-1-thiogalactopyranoside; SeMet, selenomethionine-substituted; SAD, single-wavelength anomalous diffraction; SPR, Surface Plasmon Resonance; wild-type, wt. by guest on July 16, 2017
